MINNESOTA TO GET INCREASED SHIPMENTS OF COVID-19 DRUG

Minnesota state health officials received a long-awaited shipment of an experimental antiviral drug used to treat COVID-19 patients earlier this week, that they say could benefit 180 to 325 patients. The drug, C, which is donated by the manufacturer and distributed by federal and state governments, is still in short supply even though it was approved for emergency use May 1. For the past three weeks, Minnesota has been allocated only enough vials to treat 80 to 140 patients, depending on dosages needed.